Correspondence

Retina

Volumn 29, Issue 3, 2009, Pages 415-416

  Itty, Sujit ^a   Olson, Joshua H ^b   O'Connell, Dennis J ^c   Pulido, Jose S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c InSight Retina Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE; METHOTREXATE; RITUXIMAB; STEROID; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ANTERIOR EYE CHAMBER; BLOOD RETINA BARRIER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LETTER; LYMPHOMA; NONHUMAN; OPHTHALMOSCOPY; PARACENTESIS; PIGMENT EPITHELIUM; PRIMARY INTRAOCULAR LYMPHOMA; PRIMARY TUMOR; RECURRENT CANCER; TREATMENT DURATION; UVEITIS; VISUAL ACUITY; VITRECTOMY; B CELL LYMPHOMA; EYE TUMOR; FOLLOW UP; INTRASPINAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; VITREOUS BODY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SPINAL; LYMPHOMA, B-CELL; METHOTREXATE; MIDDLE AGED; VITREOUS BODY;

EID: 67749086422     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318196b1f6     Document Type: Letter

References (8)

1. Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye 2007;21:1524-1527.
2. Pulido JS, Bakri SJ, Valyi-Nagy T, Shukla D. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina 2007;27:1071-1073.
3. Kim H, Csaky KG, Chan CC, et al. The pharmacokinetics of rituximab following an intravitreal injection. Exp Eye Res 2006; 82:760-766.
4. Ohguro N, Hashida N, Tano Y. Effect of intravitreous rituximab injections in patients with ocular lesions associated with central nervous system lymphoma. Arch Ophthalmol 2008;126:1002-1003.
5. Gunduz K, Pulido JS, McCannel CA, O'Neill BP. Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus 2006;21:E9.
6. Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 2007;18: 1851-1855.
7. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988;68:835-853.
8. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000;181:1-12.